In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.

We recently compiled a list of the Jim Cramer Recently Discussed These 15 Stocks & The California Wildfires. In this article, ...

A team of scientists at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of ...

Ratings for Moderna MRNA were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a concise overview of recent ratings ...

BioNTech SE is advancing its oncology strategy with investigational therapies BNT327/PM8002 and mRNA cancer immunotherapy candidates to establish a new immuno-oncology backbone targeting a variety ...

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Moderna Inc (Symbol: MRNA), where a total volume of 163,416 contracts has been ...

NEW YORK - Leverage Shares plc, an issuer of exchange-traded products (ETPs), has announced an intraday rebalance of its 3x Long Moderna (NASDAQ:MRNA) ETP following a significant drop in the price ...

Purified mRNA was fragmented into small pieces with fragment buffer ... with a statistical significance set at P < 0.05. Table 1 Slc transporters DEGs in liver compared between HFD group and NCD group ...

Source: FactSet Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: FactSet ...

What about an mRNA vaccine for H5N1? There isn't one yet, but several companies—including Moderna, Pfizer and GlaxoSmithKline (in collaboration with CureVac)—are working on such a shot.